Infectious Diseases

Infectious Diseases


Drug Watch

FDA Approves Oritavancin for Skin Infections

Oritavancin (Orbactiv), administered as a single dose, is the third new antibiotic approved since May for treatment of skin and soft-tissue infections.

FDA Approves Tedizolid for Skin Infections

Tedizolid, an oxazolidinone, is the second new drug approved in the last month for treatment of skin and soft tissue infections.

HIV and ID Observations Blog

CDC Recommends Broader Use of Pre-Exposure Prophylaxis — Can We Make It Happen? Free

CDC is now recommending tenofovir/FTC (Truvada) for all Americans at high risk for HIV. Dr. Paul Sax offers his thoughts on the challenges ahead.

Guideline Watch

Prevention and Control of Seasonal Influenza

An update to the recommendations for 2013–2014